Suchergebnisse
UB Katalog
Artikel & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Gefunden in
Art der Quelle
Schlagwort
- business 6 Treffer
- business.industry 6 Treffer
- medicine 6 Treffer
- medicine.disease 6 Treffer
- medicine.drug 6 Treffer
-
45 weitere Werte:
- medicine.medical_treatment 6 Treffer
- internal medicine 5 Treffer
- medicine.medical_specialty 5 Treffer
- oncology 5 Treffer
- cancer chemotherapy 3 Treffer
- cancer research 3 Treffer
- chemotherapy 3 Treffer
- immunotherapy 3 Treffer
- adjuvant therapy 2 Treffer
- antibody 2 Treffer
- breast neoplasms 2 Treffer
- breast tumors 2 Treffer
- chemistry 2 Treffer
- chemistry.chemical_compound 2 Treffer
- combined modality therapy 2 Treffer
- disease 2 Treffer
- disease remission 2 Treffer
- diseases 2 Treffer
- female 2 Treffer
- general medicine 2 Treffer
- humans 2 Treffer
- immunology 2 Treffer
- individualized treatment 2 Treffer
- interim analysis 2 Treffer
- metastatic breast cancer 2 Treffer
- neoadjuvant therapy 2 Treffer
- pathology 2 Treffer
- pertuzumab 2 Treffer
- skin and connective tissue diseases 2 Treffer
- surgery 2 Treffer
- tamoxifen 2 Treffer
- trastuzumab emtansine 2 Treffer
- 03 medical and health sciences 1 Treffer
- 0301 basic medicine 1 Treffer
- 030104 developmental biology 1 Treffer
- 0302 clinical medicine 1 Treffer
- 030220 oncology & carcinogenesis 1 Treffer
- acquired immune system 1 Treffer
- adjuvant 1 Treffer
- ado-trastuzumab emtansine 1 Treffer
- anastrozole 1 Treffer
- animals 1 Treffer
- antibodies, monoclonal, humanized 1 Treffer
- antibody-drug conjugate 1 Treffer
- antineoplastic agents 1 Treffer
Verlag
Publikation
Sprache
9 Treffer
-
In: Annals of Oncology, Jg. 28 (2017-11-01), Heft 11, S. 2768-2772Online academicJournalZugriff:
-
In: Cancer Research, Jg. 75 (2015-05-01), S. P4- (12S.)Online unknownZugriff:
-
In: Cancer Research, Jg. 76 (2016-02-15), S. S5Online unknownZugriff:
-
In: Cancers, Jg. 14 (2022-03-01), Heft 5, S. 1246-1246Online academicJournalZugriff:
-
Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockadeIn: Science translational medicine, Jg. 7 (2015-11-27), Heft 315Online unknownZugriff:
-
In: Breast (Edinburgh, Scotland), Jg. 24 (2015-09-01)Online unknownZugriff:
-
In: ESMO Open, Jg. 1 (2016), S. e000043Online unknownZugriff:
-
Dieser Titel kann aus lizenzrechtlichen Gründen nur im Campusnetz oder nach Anmeldung angezeigt werden!academicJournalZugriff: